During the past decade, No.2 Hospital Affiliated to Jilin University conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 5 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 5 clinical trials were completed. i.e. 166.7% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "No.2 Hospital Affiliated to Jilin University" are "Episodic Migraine" (1 trials), "Migraine" (1 trials), "Type 1 Diabetes" (1 trials), "Type 1 Diabetes Mellitus" (1 trials) and "Type 2 Diabetes" (1 trials). Many other conditions were trialed in "No.2 Hospital Affiliated to Jilin University" in a lesser frequency.

Most popular intervention types in "No.2 Hospital Affiliated to Jilin University" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Insulin Lispro" (2 trials), "LY2963016" (2 trials), "Lantus®" (2 trials), "Placebo" (2 trials) and "Galcanezumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "No.2 Hospital Affiliated to Jilin University" are 5 trials for "All" genders.

Currently, there are NaN active trials in "No.2 Hospital Affiliated to Jilin University". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in No.2 Hospital Affiliated to Jilin University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in No.2 Hospital Affiliated to Jilin University, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".